263 related articles for article (PubMed ID: 16258507)
1. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.
Kato N; Sasou S; Motoyama T
Mod Pathol; 2006 Jan; 19(1):83-9. PubMed ID: 16258507
[TBL] [Abstract][Full Text] [Related]
2. The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma.
Kajihara H; Yamada Y; Shigetomi H; Higashiura Y; Kobayashi H
Int J Gynecol Pathol; 2012 Jul; 31(4):304-12. PubMed ID: 22653342
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression.
Suzuki E; Kajita S; Takahashi H; Matsumoto T; Tsuruta T; Saegusa M
Lab Invest; 2015 Aug; 95(8):962-72. PubMed ID: 26030369
[TBL] [Abstract][Full Text] [Related]
5. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
Xiao W; Awadallah A; Xin W
Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
[TBL] [Abstract][Full Text] [Related]
6. Alterations in β-catenin, microsatellite instability, and HNF-1β levels are independently associated with ovarian endometriosis-associated tumorigenesis.
Tomohiro M; Matsumoto T; Miura R; Oguri Y; Yokoi A; Tochimoto M; Saegusa M
Hum Pathol; 2019 Jul; 89():10-23. PubMed ID: 31022415
[TBL] [Abstract][Full Text] [Related]
7. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
[TBL] [Abstract][Full Text] [Related]
8. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases.
Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K
Medicine (Baltimore); 2016 Mar; 95(9):e3003. PubMed ID: 26945423
[TBL] [Abstract][Full Text] [Related]
11. HNF-1β in ovarian carcinomas with serous and clear cell change.
DeLair D; Han G; Irving JA; Leung S; Ewanowich CA; Longacre TA; Gilks CB; Soslow RA
Int J Gynecol Pathol; 2013 Nov; 32(6):541-6. PubMed ID: 24071869
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma.
Li Q; Zeng X; Cheng X; Zhang J; Ji J; Wang J; Xiong K; Qi Q; Huang W
Int J Clin Exp Pathol; 2015; 8(7):8305-10. PubMed ID: 26339401
[TBL] [Abstract][Full Text] [Related]
13. The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary.
Kobayashi H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
Int J Gynecol Cancer; 2009 Apr; 19(3):471-9. PubMed ID: 19407577
[TBL] [Abstract][Full Text] [Related]
14. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL
Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
[TBL] [Abstract][Full Text] [Related]
15. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
Ayhan A; Mao TL; Seckin T; Wu CH; Guan B; Ogawa H; Futagami M; Mizukami H; Yokoyama Y; Kurman RJ; Shih IeM
Int J Gynecol Cancer; 2012 Oct; 22(8):1310-5. PubMed ID: 22976498
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma.
Okamoto T; Mandai M; Matsumura N; Yamaguchi K; Kondoh H; Amano Y; Baba T; Hamanishi J; Abiko K; Kosaka K; Murphy SK; Mori S; Konishi I
Mol Carcinog; 2015 Jan; 54(1):35-49. PubMed ID: 24105991
[TBL] [Abstract][Full Text] [Related]
17. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
Canet B; Pons C; Espinosa I; Prat J
Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary.
Kato N; Tamura G; Motoyama T
Virchows Arch; 2008 Feb; 452(2):175-80. PubMed ID: 18066692
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W
Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological heterogeneity in ovarian clear cell adenocarcinoma: a study on individual therapy practice.
Matsuo Y; Tashiro H; Yanai H; Moriya T; Katabuchi H
Med Mol Morphol; 2015 Sep; 48(3):146-54. PubMed ID: 25398420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]